Salish Bioscience
Seattle, US · Founded 2021 · Washington corporation
Founders & leadership
FP
Frank PaganelliNamed on SEC filing
CR
Chris RaymondNamed on SEC filing
KM
Kira MisuraNamed on SEC filing
FR
Fenella RaymondNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$7M disclosed across 1 round · 2022
▶$7MraisedApr 2022 · 25 investors · Other Health CareRule 506(b)
▶$7MraisedApr 2022 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank PaganelliExecutive Officer, Director
- Chris RaymondDirector
- Kira MisuraDirector
- Fenella RaymondExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Mar 2022
- Incorporated
- Corporation, Washington, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Salish Bioscience raised?
- Salish Bioscience has disclosed $7M raised across 1 round.
- Where is Salish Bioscience headquartered?
- Salish Bioscience is headquartered in Seattle, US.